Clinical utility of serum S100 in the therapy monitoring of patients with high risk malignant melanoma.

被引：0
作者：
Molina, R. [1 ]
Auge, J. M. [1 ]
Domingo, J. [1 ]
Puig, S. [1 ]
Filella, X. [1 ]
Malvehy, J. [1 ]
Castel, T. [1 ]
机构：
[1] T Castel Biochem & Genet Hosp Clin, IDIBAPS, Barcelona, Spain
来源：
TUMOR BIOLOGY | 2006年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
[1]   Clinical utility of serum S 100 and MIA in the therapy monitoring of patients with high risk malignant melanoma [J].
Auge, Josep Maria ;
Molina, R. ;
Domingo, J. ;
Puig, S. ;
Filella, X. ;
Malvehy, J. ;
Castel, T. ;
Ballesta, A. M. .
TUMOR BIOLOGY, 2006, 27 :43-43
[2]   Evaluation of the Elecsys S100 immumoassay in patients with malignant melanoma. [J].
Alber, B ;
Hein, R ;
Luppa, P .
CLINICAL CHEMISTRY, 2004, 50 (06) :A78-A78
[3]   Clinical value of S100 levels in serum of malignant melanoma patients [J].
Natalia, S. ;
Sergeeva, N. V. ;
Marshutina, M. P. ;
Mishunina, T. N. ;
Lasutina, D. D. .
TUMOR BIOLOGY, 2007, 28 :105-105
[4]   S100 IRMA: A new and prognostic tumor marker in patients with malignant melanoma. [J].
Brenner, W ;
Hauschild, A ;
Engel, G ;
Bohuslavizki, KH ;
Monig, H ;
Christophers, E ;
Henze, E .
JOURNAL OF NUCLEAR MEDICINE, 1997, 38 (05) :600-600
[5]   CLINICAL-SIGNIFICANCE OF SERUM S100 IN METASTATIC MALIGNANT-MELANOMA [J].
GUO, HB ;
STOFFELWAGNER, B ;
BIERWIRTH, T ;
MEZGER, J ;
KLINGMULLER, D .
EUROPEAN JOURNAL OF CANCER, 1995, 31A (06) :924-928
[6]   Serum S100β protein as a marker of disease activity in patients with malignant melanoma [J].
Mohammed, MQ ;
Abraha, HD ;
Sherwood, RA ;
MacRae, K ;
Retsas, S .
MEDICAL ONCOLOGY, 2001, 18 (02) :109-120
[7]   Serum protein S100β in patients with malignant melanoma detected by an immunoluminometric assay [J].
Uwe Wollina ;
Kerstin Karte ;
Uta-Christina Hipler ;
Brunhilde Knöll ;
Karsten Kirsch ;
Claudia Herold .
Journal of Cancer Research and Clinical Oncology, 2000, 126 :107-110
[8]   Serum S100β protein as a marker of disease activity in patients with malignant melanoma [J].
Mohammed M.Q. ;
Abraha H.D. ;
Sherwood R.A. ;
MacRae K. ;
Retsas S. .
Medical Oncology, 2001, 18 (2) :109-120
[9]   Serum protein S100β in patients with malignant melanoma detected by an immunoluminometric assay [J].
Wollina, U ;
Karte, K ;
Hipler, UC ;
Knöll, B ;
Kirsch, K ;
Herold, C .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2000, 126 (02) :107-110
[10]   S100 protein serum levels in cutaneous malignant melanoma [J].
Seregni, E ;
Massaron, S ;
Martinetti, A ;
Illeni, MT ;
Rovini, D ;
Belli, F ;
Agresti, R ;
Greco, M ;
Cascinelli, N ;
Bombardieri, E .
ONCOLOGY REPORTS, 1998, 5 (03) :601-604
12345